Michael Distler of D.S. Biomedical L.L.C. describes key medical electronics products including the Delta Scanner and Delta Scanner Pro which are electronic biofeedback nerve stimulators used for therapy, pain management, and rehabilitation. The devices have wireless and USB capabilities for saving patient data and represent a late stage of development with no direct competition in the US market. The potential market value of the technology is estimated between $500 million to $1 billion worldwide given its treatment applications currently used without clinical trials approval. Upon receiving necessary clearances and protections, the company intends to sell the products and intellectual property to a larger firm for global production and marketing.
